Get started
Work

A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.

Year: 2022
Type: conference-abstract
DOI: 10.1200/jco.2022.40.16_suppl.tps617
Authors: Heather L. McArthur, Elizabeth Anne Comen, Yolanda Bryce, Stephen Barnett Solomon, Jorge Henrique S. Leal, Christina DiLauro Abaya, Cristal Martinez, Reva K Basho, Dorothy J. Park, Philomena McAndrew, Brigid Larkin, William Mills, David B. Page, Staci L. Mellinger, Nicole Fredrich, Nicole Moxon, Sangeetha M. Reddy, Meredith Carter, Sujata Patil, Larry Norton
Institutions: The University of Texas Southwestern Medical Center, Memorial Sloan Kettering Cancer Center, Cedars-Sinai Medical Center, Beverly Hills Cancer Center, Providence Portland Medical Center, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4281663502
Cites:
Cited by: 3
Related to: 10